Abstract:The reduction of excessive weight remains a major public health challenge, with control currently limited to a calorie reduction strategy. Currently, attempts are being made at revisiting the fibre hypothesis based on the African studies of Denis Burkitt, that the lack of dietary fibre in the modern diet was responsible for the occurrence of obesity and many of the other non-communicable diseases of what he called “Western civilization”. However, the dilemma is that Burkitt himself stressed that other peoples of his day, such as the Maasai, remained healthy without consuming such high fibre diets. Equally, the present obesity epidemic is accompanied by diseases of a malfunctioning immune system and of poor mental health that do not seem to be adequately explained simply by a deficiency of dietary fibre. Though unknown in Burkitt’s day, an increasing degradation of a mutualistic intestinal microbiome would offer a better fit to the observed epidemiology, especially if the microbiome is not effectively passed on from mother to child at birth. Taking the broader view, in this article we posit a view of the microbiome as a cofactor of mammalian evolution, in which a maternal microbial inheritance complements the parental genetic inheritance of the animal, both engaging epigenetic processes. As this would require the microbiome to be fully integrated with the animal as it develops into an adult, so we have a meaningful evolutionary role for the microbiome–gut–brain axis. By a failure to correctly establish a microbiome–gut interface, the inhibition of maternal microbial inheritance sets the scene for the future development of non-communicable disease: compromised immune system function on the one hand and dysfunctional gut–brain communication on the other. The basic principle is that the fully functioning, diverse, microbiome achieves interkingdom communication by the generation of messenger chemicals, semiochemicals. It is envisaged that the in situ detection of these as yet ill-defined chemical entities by means of an ingestible sensor would indicate the severity of disease and provide a guide as to its amelioration.

Unraveling the roles of Gut microbiota in predisposition to and progression of obesity and related metabolic disorders

Functional Dynamics of Gut Microbiota in Obesity and Metabolic Diseases

Microbiome–Gut Dissociation: Investigating the Origins of Obesity

Research advance in the relationship between the gut microbiota and obesity

The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities

Role of oral and gut microbiota in childhood obesity

Contribution of Diet to Gut Microbiota and Related Host Cardiometabolic Health: Diet-Gut Interaction in Human Health.

The critical role of gut microbiota in obesity

The links between gut microbiota and obesity and obesity related diseases

Targeting the Gut Microbiota for Remediating Obesity and Related Metabolic Disorders

The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective

Gut microbiota in obesity and metabolic disorders

High Fat Diet, Gut Microbiota and Metabolic Health

The Role of Gut Microbiota Modulation Strategies in Obesity: The Applications and Mechanisms

Effect of the Gut Microbiota on Obesity and Its Underlying Mechanisms： an Update

Research Progress on the Role of Intestinal Flora in Obesity and Diabetes Intervention

Gut microbiota and its metabolites: Bridge of dietary nutrients and obesity-related diseases

Whole-body systems approaches for gut microbiota-targeted, preventive healthcare.

Gut Microbiome Interventions in Human Health and Diseases

The microbiome's influence on obesity: mechanisms and therapeutic potential

The Gut Microbiota and Obesity: from Correlation to Causality